New Post

GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with coronary CT angiography

Chalfont St. Giles, UK, – Broadening its range of diagnostic options for clinicians and their patients, GE Healthcare announced today that it has received an indication approval from the U.S. Food and Drug Administration (FDA) for its imaging agent Visipaque™ (iodixanol) Injection. Visipaque 320 mg Iodine/mL is an iso-osmolar agent that is now approved for […]

Read More

The Cost of a Polluted Environment: 1.7 million Child Deaths a Year, Says WHO

GENEVA – More than 1 in 4 deaths of children under 5 years of age are attributable to unhealthy environments. Every year, environmental risks – such as indoor and outdoor air pollution, second-hand smoke, unsafe water, lack of sanitation, and inadequate hygiene – take the lives of 1.7 million children under 5 years, say two […]

Read More

GE Healthcare expands MRI contrast media product range in Europe with launch of macrocyclic agent Clariscan

VIENNA, AUSTRIA – Growing its range of magnetic resonance imaging (MRI) contrast media options available to patients and radiologists, GE Healthcare today announced the launch of Clariscan™ (gadoteric acid) at the European Congress of Radiology (ECR) 2017 meeting. Clariscan is a gadolinium-based contrast agent (GBCA) designed to support effective visualisation of abnormalities in the brain, […]

Read More

Funding Available for Kansas Organizations Improving Access to Health Care in Rural and Frontier Areas

Grants ranging from $40,000 to $50,000 will support organizations that address health needs for Kansans who live in rural and frontier areas Programs must encourage a “whole person” approach to care, leverage telehealth or incorporate community health workers UnitedHealthcare accepting RFPs by nonprofits, Federally Qualified Health Centers and other organizations at communitygrants@uhc.com TOPEKA, Kan. (Feb. […]

Read More

McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims

SAN FRANCISCO– McKesson Corporation (NYSE:MCK) today announced that it has finalized administrative and civil settlements to resolve U.S. Drug Enforcement Administration (DEA) and U.S. Department of Justice (DOJ) potential federal civil and administrative claims regarding McKesson’s monitoring and reporting of suspicious controlled substance orders. The reporting practices dating back to 2009, and challenged by the […]

Read More

Boston Children’s Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders

Chicago, Illinois – Boston Children’s Hospital and GE Healthcare today announced a collaboration to develop and commercialize digital solutions to advance the diagnosis and treatment of specific childhood diseases – starting with diseases that affect the brain. The first project, detailed today at the 102nd annual meeting of the Radiological Society of North America in […]

Read More

UN Agencies Scaling Up Emergency Health Services As Mosul Is Made Accessible

United Nations agencies are rapidly scaling up efforts in eastern Mosul to ensure that more than 60,000 people living near the frontlines of the current military operations have access to life-saving care. Two World Health Organization (WHO) clinics were recently deployed in the city to provide residents with health services aid for the first time […]

Read More

WellCare to Acquire Universal American Corp.

TAMPA, Fla. and WHITE PLAINS, N.Y., Nov. 17, 2016 — WellCare Health Plans, Inc. (NYSE: WCG) and Universal American Corp. (NYSE: UAM) announced today that they have entered into a definitive agreement under which WellCare will acquire Universal American in an all cash transaction valued at $10.00 per share of common stock. This represents a […]

Read More

US Labor Secretary Perez’s Stresses Need For Affordable Child Care

WASHINGTON – The U.S. Department of Labor’s blog today features a post by U.S. Secretary of Labor Thomas E. Perez on the importance of affordable child care for America’s working families. Please find the post’s text below, or read it here: “Young children can’t be left alone when a parent goes to work. But too […]

Read More

Mylan to Launch First Generic to EpiPen® Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product

HERTFORDSHIRE, England and PITTSBURGH, Aug. 29, 2016 – Mylan N.V. (NASDAQ, TASE: MYL) today announced that its U.S. subsidiary will launch the first generic to EpiPen® Auto-Injector (epinephrine injection, USP) at a list price of $300 per generic EpiPen® two-pack carton, which represents a discount of more than 50% to the Mylan list price, or […]

Read More